Recently, FBXL7 promoter hypermethylation was associated with the FBXL7 silencing and overexpression of its target protein, c-SRC, increasing metastasis promotion in prostate and pancreatic cancers [4]. Here, SRC is linked to familial pancreatic carcinoma.